Summary
Alethia Biotherapeutics
Founded in 2002
Description
Alethia Biotherapeutics is a biotechnology company based out of Montreal, QC, Canada. They are developing monoclonal antibody based therapeutics for cancer associated diseases, with a focus on cancer associated epithelial to mesenchymal transition. The...
Strengths
- Alethia Biotherapeutics has a strong market share in their industry
- Revenue growth is more steady than the industry average
Weaknesses
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Since Alethia Biotherapeutics was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
Alethia Biotherapeutics's annual revenue
$5385000
Based on Kona Equity data
-
Revenue per employee
$359000
-
Variance of revenue growth
0.05
-
Annual revenue growth since founding
$244772
-
Revenue growth rate from first known quarter to current
-38.8%
Employee Count
15 employees
-
Employee growth rate from first known quarter to current
-36.4%
Executives
Yves Cornellier
President & Chief Executive Officer
y**@alethiabio.comJulie Laurin
Director, Ph D, Preclinical Drug Development
j**@alethiabio.comJacques Jolivet
Chief Medical Officer
j**@alethiabio.comNatacha Duquette
Technicienne Sante Animale
n**@alethiabio.comXavier Mendez
Biomedical Engineer
x**@alethiabio.comRoula Khoury
Executive Assistant
r**@alethiabio.comElisabeth Viau
Drug Development & Clinical Research Associate
e**@alethiabio.comMarbelis Francisco
Research Assistant
m**@alethiabio.comHéloïse Vuong
Research & Development Scientist
h**@alethiabio.comPhone Biotherapeutics
President & Chief Executive Officer
p**@alethiabio.comG Score - 2
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
- G1 Revenue is greater than the industry median.
- G5 Variance of revenue growth is less than the industry average
Location
Unlock unlimited leads
Similar Companies
Key Information
- Name: Alethia Biotherapeutics
- Category: Pharmaceuticals
- Industry: Biotechnology Company
- SIC: 283; 28
- NAICS: 5417; 541
See similar companies
-
By City Montreal Small Biotechnology Company in Montreal Mid-size Biotechnology Company in Montreal Pharmaceuticals in Montreal Small Pharmaceuticals in Montreal Mid-size Pharmaceuticals in Montreal
-
By State Quebec Small companies in Quebec Pharmaceuticals in Quebec Small Pharmaceuticals in Quebec Mid-size Pharmaceuticals in Quebec Small Biotechnology Company in Quebec Mid-size Biotechnology Company in Quebec
-
By Category Pharmaceuticals Small Pharmaceuticals Mid-size Pharmaceuticals
-
By Industry Biotechnology Company Small Biotechnology Company Mid-size Biotechnology Company Pharmaceuticals and Biotechnology Company
-
Firmographic data G Score of 2 Founded in 2002 SIC: 283 SIC: 28 NAICS: 5417 NAICS: 541 #Biotechnology #Pharmaceuticals #Healthcare
Frequently Asked Questions
Alethia Biotherapeutics's headquarters are located at 141, Prsident-Kennedy Ave Ste SB-5100 Montreal, Quebec H2X 1Y4.
Alethia Biotherapeutics's official website is alethiabio.com
Alethia Biotherapeutics's annual revenue is $5.4 M.
Alethia Biotherapeutics's SIC: 283; 28
Alethia Biotherapeutics's NAICS: 5417; 541.
Alethia Biotherapeutics has 15 employees
Alethia Biotherapeutics is in the industry of Pharmaceuticals.